Flexiplan 3D and 3D+
System, Planning, Radiation Therapy Treatment. 510(k) K091145, from Isodose Control B.V. (Ede, NL). Product code MUJ, class 2.
As of Nov 20, 2026, K091145 is an FDA 510(k) held by Isodose Control B.V., substantially equivalent on May 27, 2009 after 37 days, with no recalls tied to it in FDA's recall database.
- Review time: 37 days
- Recalls: 0
- Cited as a predicate by: 1 device
Flexiplan is a Brachytherapy Treatment Planning System used by medical professionals. Flexiplan is used for the creation of HDR or PDR treatment plans for remote afterloader based brachytherapy. It especially supports the Flexitron Remote Afterloader from Isodose Control. Flexiplan calculates a proposed treatment course based on imported clinical images and other user entered data.
- Flexiplan Brachytherapy Treatment Planning SystemK081112 · Isodose Control B.V. · Jul 29, 2008
- Hdrplus, Add In Prostate Module for HdrplusK123263 · Eckert & Ziegler Bebig GmbH · Apr 4, 2013
- RT Elements (4.6)K261655 · Brainlab SE · Oct 5, 2026
- Virtual Cone (1.0)K260750 · Varian Medical Systems, Inc. · Jul 8, 2026
- RadOncAIK253050 · Informai · Jun 18, 2026
- Multimodality Simulation Workspace (MM Sim) (v1.0.0)K260207 · Philips Medical Systems Nederland B.V. · May 27, 2026
- eXaSkin PlusK252784 · Anatomical Geometry S.L. · May 22, 2026
- ART.1-USK253078 · Seetreat Pty, Ltd. · May 14, 2026
- syngo.via RT Image Suite VC10K252304 · Varian Medical Systems, Inc. · Mar 18, 2026
- Monaco RTP System (6.3)K252002 · Elekta Solutions AB · Feb 19, 2026
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Apr 20, 2009
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5050
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files